Marshall Wace, LLP Pulmonx Corp Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Pulmonx Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 123,313 shares of LUNG stock, worth $781,804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,313
Previous 84,787
45.44%
Holding current value
$781,804
Previous $1.08 Million
5.74%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
30.8MCall Options Held
1.2KPut Options Held
1.2K-
Primecap Management CO Pasadena, CA5.74MShares$36.4 Million0.04% of portfolio
-
Black Rock Inc. New York, NY3.04MShares$19.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.72MShares$17.2 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.65MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$13.2 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $236M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...